<DOC>
	<DOC>NCT01532921</DOC>
	<brief_summary>Few clinical evidence for the Contour 3D Tricuspid Annuloplasty Ring exists; therefore, in order to position this product on the market, a post-market release study will be completed. The purpose of this study is to evaluate the hemodynamic performance of the Contour 3D® Tricuspid Annuloplasty Ring following Tricuspid Valve repair in a post-market environment.</brief_summary>
	<brief_title>EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of Contour 3D® in TRICUSPID Valve Annuloplasty</brief_title>
	<detailed_description />
	<mesh_term>Tricuspid Valve Insufficiency</mesh_term>
	<criteria>Willing to sign and date the Patient Informed Consent (PIC) Indicated for a concomitant surgical repair of the TV Willing to return to the hospital, where the implantation originally occurred, for a 6 month followup visit Patients with a degenerative TV condition Patients with primary TV regurgitation Previous TV repair or replacement Standalone TV repair Already participating in another investigational device or drug study, possibly leading to bias and jeopardizing the scientific appropriate assessment of the study endpoints Life expectancy of less than one year Pregnant or desire to be pregnant within 12 months of the study treatment Under 18 years or over 85 years of age Patients with active endocarditis Patients with valvular retraction with severely reduced mobility Patients with a heavily calcified TV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>